LncRNAs: key players and novel insights into cervical cancer

Tumor Biology

Volumn 37, Issue 3, 2016, Pages 2779-2788

  Peng, Li ^a,b,c   Yuan, Xiaoqing ^a   Jiang, Binyuan ^a,b,c   Tang, Zaili ^d   Li, Guan Cheng ^a,b,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b National Health and Family Planning Commission   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^d UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

ceRNA; Cervical cancer; Dysregulation; EMT; EZH2; Function; GAS5; HOTAIR; LncRNA; LncRNA ANRIL; LncRNA CCHE1; LncRNA EBIC; LncRNA LET; m6A; MALAT1; Mechanism; MEG3; NEAT2; TUSC8; Xist

Indexed keywords

HUMAN PAPILLOMAVIRUS PROTEIN; LONG UNTRANSLATED RNA; MICRORNA; TUMOR MARKER; UNCLASSIFIED DRUG; VIRUS PROTEIN;

APOPTOSIS; CANCER GROWTH; CANCER PROGNOSIS; CELL PROLIFERATION; GENE FUNCTION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; METASTASIS; PREDICTION; PRIORITY JOURNAL; PROTEIN RNA BINDING; RADIOSENSITIVITY; REVIEW; RNA METHYLATION; TUMOR INVASION; UTERINE CERVIX CANCER; DISEASE COURSE; FEMALE; GENETICS; MORTALITY; PATHOLOGY; PHYSIOLOGY; RADIATION TOLERANCE; UTERINE CERVIX TUMOR;

APOPTOSIS; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RADIATION TOLERANCE; RNA, LONG NONCODING; UTERINE CERVICAL NEOPLASMS;

EID: 84951994908     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-4663-9     Document Type: Review

References (91)

1. Ma MZ, Chu BF, Zhang Y, Weng MZ, Qin YY, Gong W, et al. Long non-coding rna ccat1 promotes gallbladder cancer development via negative modulation of mirna-218-5p. Cell Death Dis. 2015;6:e1583.
2. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57–74.
3. Zhao Y, Wang J, Chen X, Luo H, Xiao Y, Chen R. Large-scale study of long non-coding rna functions based on structure and expression features. Sci China Life Sci. 2013;56:953–9.
4. He JH, Han ZP, Li YG. Association between long non-coding rna and human rare diseases. Biomed Rep. 2014;2:19–23.
5. Ernst C, Morton CC. Identification and function of long non-coding rna. Front Cell Neurosci. 2013;7:168.
6. Ip JY, Nakagawa S. Long non-coding rnas in nuclear bodies. Dev Growth Differ. 2012;54:44–54.
7. Ye N, Wang B, Quan ZF, Cao SJ, Wen XT, Huang Y, et al. Functional roles of long non-coding rna in human breast cancer. Asian Pac J Cancer Prev. 2014;15:5993–7.
8. Mercer TR, Dinger ME, Mattick JS. LONG Non-coding rnas: insights into functions. Nat Rev Genet. 2009;10:155–9.
9. Di Gesualdo F, Capaccioli S, Lulli M. A pathophysiological view of the long non-coding rna world. Oncotarget. 2014;5:10976–96.
10. Sun L, Luo H, Liao Q, Bu D, Zhao G, Liu C, et al. Systematic study of human long intergenic non-coding rnas and their impact on cancer. Sci China Life Sci. 2013;56:324–34.
11. Ling H, Vincent K, Pichler M, Fodde R, Berindan-Neagoe I, Slack FJ, Calin GA. Junk DNA and the long non-coding rna twist in cancer genetics. Oncogene. 2015;34:5003–11
12. Liu S, Zhang P, Chen Z, Liu M, Li X, Tang H. Microrna-7 downregulates xiap expression to suppress cell growth and promote apoptosis in cervical cancer cells. FEBS Lett. 2013;587:2247–53.
13. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011;378:1461–84.
14. Ojesina AI, Lichtenstein L, Freeman SS, Pedamallu CS, Imaz-Rosshandler I, Pugh TJ, et al. Landscape of genomic alterations in cervical carcinomas. Nature. 2014;506:371–5.
15. Wang IT, Chou SC, Lin YC. Zoledronic acid induces apoptosis and autophagy in cervical cancer cells. Tumour Biol 2014;35:11913–20.
16. Kulkarni PR, Rani H, Vimalambike MG, Ravishankar S. Opportunistic screening for cervical cancer in a tertiary hospital in karnataka, india. Asian Pac J Cancer Prev. 2013;14:5101–5.
17. El Mhamdi S, Bouanene I, Mhirsi A, Bouden W, Soussi Soltani M. Cervical cancer screening: Women's knowledge, attitudes, and practices in the region of monastir (tunisia). Rev Epidemiol Sante Publique. 2012;60:431–6.
18. Sun M, Kraus WL. Minireview: long noncoding rnas: new "links" between gene expression and cellular outcomes in endocrinology. Mol Endocrinol. 2013;27:1390–402.
19. Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding rnas. Cell. 2009;136:629–41.
20. Ma L, Bajic VB, Zhang Z. On the classification of long non-coding rnas. RNA Biol. 2013;10:925–33.
21. Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding rna point of view. RNA Biol. 2012;9:703–19.
22. He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv XW, et al. Long noncoding rnas: novel insights into hepatocellular carcinoma. Cancer Lett. 2014;344:20–7.
23. Clark MB, Mattick JS. Long noncoding rnas in cell biology. Semin Cell Dev Biol. 2011;22:366–76.
24. Fang XY, Pan HF, Leng RX, Ye DQ. Long noncoding rnas: novel insights into gastric cancer. Cancer Lett. 2015;356:357–66.
25. Wang KC, Chang HY. Molecular mechanisms of long noncoding rnas. Mol Cell. 2011;43:904–14.
26. Smolle M, Uranitsch S, Gerger A, Pichler M, Haybaeck J. Current status of long non-coding rnas in human cancer with specific focus on colorectal cancer. Int J Mol Sci. 2014;15:13993–4013.
27. Tong YS, Wang XW, Zhou XL, Liu ZH, Yang TX, Shi WH, et al. Identification of the long non-coding rna pou3f3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma. Mol Cancer. 2015;14:3.
28. Kunej T, Obsteter J, Pogacar Z, Horvat S, Calin GA. The decalog of long non-coding rna involvement in cancer diagnosis and monitoring. Crit Rev Clin Lab Sci. 2014;51:344–57.
29. Hu Y, Chen HY, Yu CY, Xu J, Wang JL, Qian J, et al. A long non-coding rna signature to improve prognosis prediction of colorectal cancer. Oncotarget. 2014;5:2230–42.
30. Xu MD, Qi P, Weng WW, Shen XH, Ni SJ, Dong L, et al. Long non-coding rna lsinct5 predicts negative prognosis and exhibits oncogenic activity in gastric cancer. Medicine (Baltimore). 2014;93:e303.
31. Hauptman N, Glavac D. Long non-coding rna in cancer. Int J Mol Sci. 2013;14:4655–69.
32. Wu Y, Zhang L, Wang Y, Li H, Ren X, Wei F, et al. Long noncoding rna hotair involvement in cancer. Tumour Biol. 2014;35:9531–8.
33. Huang L, Liao LM, Liu AW, Wu JB, Cheng XL, Lin JX, et al. Overexpression of long noncoding rna hotair predicts a poor prognosis in patients with cervical cancer. Arch Gynecol Obstet. 2014;290:717–23.
34. Li J, Wang Y, Yu J, Dong R, Qiu H. A high level of circulating hotair is associated with progression and poor prognosis of cervical cancer. Tumour Biol. 2015;36:1661–5.
35. Kim HJ, Lee DW, Yim GW, Nam EJ, Kim S, Kim SW, et al. Long non-coding rna hotair is associated with human cervical cancer progression. Int J Oncol. 2015;46:521–30.
36. Schneider C, King RM, Philipson L. Genes specifically expressed at growth arrest of mammalian cells. Cell. 1988;54:787–93.
37. Nakamura Y, Takahashi N, Kakegawa E, Yoshida K, Ito Y, Kayano H, et al. The gas5 (growth arrest-specific transcript 5) gene fuses to bcl6 as a result of t(1;3)(q25;q27) in a patient with b-cell lymphoma. Cancer Genet Cytogenet. 2008;182:144–9.
38. Cao S, Liu W, Li F, Zhao W, Qin C. Decreased expression of lncrna gas5 predicts a poor prognosis in cervical cancer. Int J Clin Exp Pathol. 2014;7:6776–83.
39. Liao LM, Sun XY, Liu AW, Wu JB, Cheng XL, Lin JX, et al. Low expression of long noncoding xloc_010588 indicates a poor prognosis and promotes proliferation through upregulation of c-myc in cervical cancer. Gynecol Oncol. 2014;133:616–23.
40. Yang F, Huo XS, Yuan SX, Zhang L, Zhou WP, Wang F, et al. Repression of the long noncoding rna-let by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol Cell. 2013;49:1083–96.
41. Jiang S, Wang HL, Yang J. Low expression of long non-coding rna let inhibits carcinogenesis of cervical cancer. Int J Clin Exp Pathol. 2015;8:806–11.
42. Malek E, Jagannathan S, Driscoll JJ. Correlation of long non-coding rna expression with metastasis, drug resistance and clinical outcome in cancer. Oncotarget. 2014;5:8027–38.
43. Cao R, Zhang Y. The functions of e(z)/ezh2-mediated methylation of lysine 27 in histone h3. Curr Opin Genet Dev. 2004;14:155–64.
44. Fang J, Zhang M, Li Q. Enhancer of zeste homolog 2 expression is associated with tumor cell proliferation and invasion in cervical cancer. Am J Med Sci. 2011;342:198–204.
45. Liu Y, Liu T, Bao X, He M, Li L, Yang X. Increased ezh2 expression is associated with proliferation and progression of cervical cancer and indicates a poor prognosis. Int J Gynecol Pathol. 2014;33:218–24.
46. Sun NX, Ye C, Zhao Q, Zhang Q, Xu C, Wang SB, et al. Long noncoding rna-ebic promotes tumor cell invasion by binding to ezh2 and repressing e-cadherin in cervical cancer. PLoS One. 2014;9:e100340.
47. Gutschner T, Hammerle M, Diederichs S. Malat1—a paradigm for long noncoding rna function in cancer. J Mol Med (Berl). 2013;91:791–801.
48. Guo F, Li Y, Liu Y, Wang J, Li G. Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in caski human cervical cancer cells suppresses cell proliferation and invasion. Acta Biochim Biophys Sin (Shanghai). 2010;42:224–9.
49. Yang L, Bai HS, Deng Y, Fan L. High malat1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion. Eur Rev Med Pharmacol Sci. 2015;19:3187–93.
50. Liu S, Song L, Zeng S, Zhang L. Malat1-mir-124-rbg2 axis is involved in growth and invasion of hr-hpv-positive cervical cancer cells. Tumour Biol. 2015. doi:10.1007/s13277-015-3732-4.
51. Zheng P, Xiong Q, Wu Y, Chen Y, Chen Z, Fleming J, et al. Quantitative proteomics analysis reveals novel insights into mechanisms of action of long noncoding rna hotair in hela cells. Mol Cell Proteomics. 2015;14:1447–1463.
52. Naemura M, Murasaki C, Inoue Y, Okamoto H, Kotake Y. Long noncoding rna anril regulates proliferation of non-small cell lung cancer and cervical cancer cells. Anticancer Res. 2015;35:5377–82.
53. Yang M, Zhai X, Xia B, Wang Y, Lou G. Long noncoding rna cche1 promotes cervical cancer cell proliferation via upregulating pcna. Tumour Biol. 2015;36:7615–22.
54. Benetatos L, Vartholomatos G, Hatzimichael E. Meg3 imprinted gene contribution in tumorigenesis. Int J Cancer. 2011;129:773–9.
55. Sheng X, Li J, Yang L, Chen Z, Zhao Q, Tan L, et al. Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding rna, in the development of epithelial ovarian cancer. Oncol Rep. 2014;32:277–85.
56. Yin DD, Liu ZJ, Zhang E, Kong R, Zhang ZH, Guo RH. Decreased expression of long noncoding rna meg3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Tumour Biol. 2015;36:4851–59.
57. Sun M, Xia R, Jin F, Xu T, Liu Z, De W, et al. Downregulated long noncoding rna meg3 is associated with poor prognosis and promotes cell proliferation in gastric cancer. Tumour Biol. 2014;35:1065–73.
58. Qin R, Chen Z, Ding Y, Hao J, Hu J, Guo F. Long non-coding rna meg3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis. Neoplasma. 2013;60:486–92.
59. Zhang J, Yao T, Wang Y, Yu J, Liu Y, Lin Z. Long noncoding rna meg3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating mir-21. Cancer Biol Ther. 2015. doi:10.1080/15384047.2015.1108496.
60. Harries LW. Long non-coding rnas and human disease. Biochem Soc Trans. 2012;40:902–6.
61. Lipovich L, Johnson R, Lin CY. Macrorna underdogs in a microrna world: evolutionary, regulatory, and biomedical significance of mammalian long non-protein-coding rna. Biochim Biophys Acta. 1799;2010:597–615.
62. Jing L, Yuan W, Ruofan D, Jinjin Y, Haifeng Q. Hotair enhanced aggressive biological behaviors and induced radio-resistance via inhibiting p21 in cervical cancer. Tumour Biol. 2015;36:3611–3619.
63. Lu H, He Y, Lin L, Qi Z, Ma L, Li L, Su Y. Long non-coding rna malat1 modulates radiosensitivity of hr-hpv + cervical cancer via sponging mir-145. Tumour Biol. 2015. doi:10.1007/s13277-015-3946-5.
64. Wang GY, Zhu YY, Zhang YQ. The functional role of long non-coding rna in digestive system carcinomas. Bull Cancer. 2014;101:E27–31.
65. Maass PG, Luft FC, Bahring S. Long non-coding rna in health and disease. J Mol Med (Berl). 2014;92:337–46.
66. Chen J, Fu Z, Ji C, Gu P, Xu P, Yu N, et al. Systematic gene microarray analysis of the lncrna expression profiles in human uterine cervix carcinoma. Biomed Pharmacother. 2015;72:83–90.
67. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A cerna hypothesis: the Rosetta stone of a hidden rna language? Cell. 2011;146:353–8.
68. Peng L, Yuan XQ, Li GC. The emerging landscape of circular rna cirs-7 in cancer. Oncol Rep. 2015;33:2669–74.
69. Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB, Yin DD, et al. Lnc rna hotair functions as a competing endogenous rna to regulate her2 expression by sponging mir-331-3p in gastric cancer. Mol Cancer. 2014;13:92.
70. Yan B, Liu J, Yao J, Li X, Wang X, Li Y, et al. Lncrna-miat regulates microvascular dysfunction by functioning as a competing endogenous rna. Circ Res. 2015;116:1143–56.
71. Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ, Tao QF, et al. A long noncoding rna activated by tgf-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell. 2014;25:666–81.
72. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (ibscc) study group. J Natl Cancer Inst. 1995;87:796–802.
73. Greco D, Kivi N, Qian K, Leivonen SK, Auvinen P, Auvinen E. Human papillomavirus 16 e5 modulates the expression of host micrornas. PLoS One. 2011;6. e21646.
74. Sasagawa T, Takagi H, Makinoda S. Immune responses against human papillomavirus (hpv) infection and evasion of host defense in cervical cancer. J Infect Chemother. 2012;18:807–15.
75. Khorasanizadeh F, Hassanloo J, Khaksar N, Mohammad Taheri S, Marzaban M, HR B, et al. Epidemiology of cervical cancer and human papilloma virus infection among iranian women - analyses of national data and systematic review of the literature. Gynecol Oncol. 2013;128:277–81.
76. Slomovitz BM, Sun CC, Frumovitz M, Soliman PT, Schmeler KM, Pearson HC, et al. Are women ready for the hpv vaccine? Gynecol Oncol. 2006;103:151–4.
77. zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology. 1991;184:9–13.
78. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003;16:1–17.
79. Sharma S, Mandal P, Sadhukhan T, Roy Chowdhury R, Ranjan Mondal N, Chakravarty B, et al. Bridging links between long noncoding rna hotair and hpv oncoprotein e7 in cervical cancer pathogenesis. Sci Rep. 2015;5:11724.
80. Leung CO, Deng W, Ye TM, Ngan HY, Tsao SW, Cheung AN, et al. Mir-135a leads to cervical cancer cell transformation through regulation of beta-catenin via a siah1-dependent ubiquitin proteosomal pathway. Carcinogenesis. 2014;35:1931–40.
81. Martinez I, Gardiner AS, Board KF, Monzon FA, Edwards RP, Khan SA. Human papillomavirus type 16 reduces the expression of microrna-218 in cervical carcinoma cells. Oncogene. 2008;27:2575–82.
82. Nilsen TW. Molecular biology. Internal mrna methylation finally finds functions. Science. 2014;343:1207–8.
83. Liu N, Pan T. Rna epigenetics. Transl Res. 2015;165:28–35.
84. Ping XL, Sun BF, Wang L, Xiao W, Yang X, Wang WJ, et al. Mammalian wtap is a regulatory subunit of the rna n6-methyladenosine methyltransferase. Cell Res. 2014;24:177–89.
85. Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y, et al. N6-methyladenosine in nuclear rna is a major substrate of the obesity-associated fto. Nat Chem Biol. 2011;7:885–7.
86. Zheng G, Dahl JA, Niu Y, Fedorcsak P, Huang CM, Li CJ, et al. Alkbh5 is a mammalian rna demethylase that impacts rna metabolism and mouse fertility. Mol Cell. 2013;49:18–29.
87. Liu N, Parisien M, Dai Q, Zheng G, He C, Pan T. Probing n6-methyladenosine rna modification status at single nucleotide resolution in mrna and long noncoding rna. RNA. 2013;19:1848–56.
88. Lee JT. Epigenetic regulation by long noncoding rnas. Science. 2012;338:1435–9.
89. Morlando M, Ballarino M, Fatica A, Bozzoni I. The role of long noncoding rnas in the epigenetic control of gene expression. ChemMedChem. 2014;9:505–10.
90. Mercer TR, Mattick JS. Structure and function of long noncoding rnas in epigenetic regulation. Nat Struct Mol Biol. 2013;20:300–7.
91. Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, et al. The nuclear-retained noncoding rna malat1 regulates alternative splicing by modulating sr splicing factor phosphorylation. Mol Cell. 2010;39:925–38.